Neurological Surgery participates in SENSE neuromodulation clinical trial

Spine

Rockville Centre, N.Y.-based Neurological Surgery is participating in the national SENSE — Subcutaneous and Epidural Neuromodulation System Evaluation — clinical trial.

The trial examines two types of neuromodulation approaches — peripheral nerve field stimulation and spinal cord stimulation — to determine whether combining the two therapies provides more relief from chronic low back and leg pain than spinal cord stimulation alone.

 

The Neurological Surgery arm of the study is led by fellowship-trained neurosurgeon Brian J. Snyder, MD, who serves director of functional and restorative neurosurgery at Winthrop-University Hospital in Mineola, N.Y.

 

"Patients are often referred to me after repeated spine surgeries fail to relieve their low back and leg pain and they have tried multiple nonsurgical treatments," said Dr. Snyder.  "Both of the therapies in the SENSE study have the potential to offer pain relief when spine surgery does not help. With this study, we will be able to get reliable data on whether the therapies should be combined for some patients."

More articles on spine:

Artificial disc replacement success story: Dr. Scott Blumenthal changes patient's life
5 points on how diabetes impacts spine surgery outcomes
Cervical fusion quality & cost: Does BMP make a difference? 5 key findings

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.